The DCAT Pulse

The DCAT Pulse


About The DCAT Pulse

Developed by DCAT volunteer committees, The DCAT Pulse is a member-focused insights hub designed to grow and evolve as an essential resource for the DCAT community. This initiative delivers timely and practical insights from trusted voices across the global bio/pharmaceutical business ecosystem and DCAT Member Companies. Through a variety of engaging formats—including webinars, podcasts, videos, infographics, and reports—The DCAT Pulse brings together fresh perspectives and seasoned expertise, spotlighting trends and opportunities that help DCAT Members stay informed, engaged, and ahead.

Stay tuned for the latest editions of The DCAT Pulse.

Webinar

Supply Planning: Are Foreign Trade Zones The Right Tool?

Brought to you by the Supply Management Committee.

On-demand viewing is available for this 30-minute webinar to gain a practical understanding of how Foreign-Trade Zones can support your organization’s supply chain strategy amid ongoing tariff uncertainty, evolving trade policies, and rapidly changing customs regulations.

LEARN MORE

Member Insights Hub

WATCH VIDEO NOW

A Conversation with Inspiring Female Leaders

May 2026
Brought to you by the Alliance for Industry Women Committee

Female leaders from across the DCAT community share authentic stories, actionable insights, and strategies for navigating uncertainty and growthy — both personally and professionally.

LEARN MORE >

AVAILABLE TO VIEW

Careers in Pharma: A Q&A with Industry Professionals

February 2026
Brought to you by the Science & Scholarship Committee

In this interactive webinar, professionals from across the bio/pharmaceutical industry share what they do, how they got there, and what they wish they’d known as students.

LEARN MORE >

ON-DEMAND VIEWING AVAILABLE

Webinar: The Tariff Outlook & Pharma

January 2026
Brought to you by the Supply Management Committee

Hear expert perspectives on current U.S. tariff policy and what lies ahead in 2026, with practical takeaways for supply planning, cost structure, and pharma manufacturing strategy.

LEARN MORE >